Interferon-γ release assay in people infected with immunodeficiency virus

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 402-404

  Bua, A ^a   Molicotti, P ^a   Ruggeri, M ^a   Madeddu, G ^a   Ferrandu, G ^a   Mura, M S ^a   Zanetti, S ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

CD4 cell count; HIV; HIV viral load; QuantiFERON; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; FALSE NEGATIVE RESULT; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; VIRUS LOAD;

EID: 79751517031     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03251.x     Document Type: Article

References (11)

1. Chin DP, Osmond D, Page-Shafer K et al. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1996; 153: 1982-1984.
2. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422.
3. Harada N, Higuchi K, Yoshiyama T et al. Comparison of the sensitivity and specifi city of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008; 56: 348-353.
4. Katiyar SK, Sampath A, Bihari S, Mamtani M et al. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 2: 1146-1152.
5. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
6. Bua A, Molicotti P, Delogu G et al. QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol 2007; 30: 477-480.
7. Palazzo R, Spensieri F, Massari M et al. Use of whole-blood samples in in-house bulk and singlecell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 2008; 15: 327-337.
8. Mazurek GH, Zajdowicz MJ, Hankinson AL et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon gamma release assays. Clin Infect Dis 2007; 45: 826-836.
9. Raby E, Moyo M, Devendra A, Banda J, De HP et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS ONE 2008; 3: e2489.
10. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007; 44: 69-73.
11. Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111. Review.